Literature DB >> 19294412

Postoperative hemorrhagic complications after elective laparoscopic cholecystectomy in patients receiving long-term anticoagulant therapy.

Metin Ercan1, Erdal B Bostanci, Ilter Ozer, Murat Ulas, Yusuf B Ozogul, Zafer Teke, Musa Akoglu.   

Abstract

BACKGROUND AND AIMS: Among patients on long-term anticoagulant therapy who undergo laparoscopic cholecystectomy (LC), bleeding complications have not been extensively investigated. The objective of this study was therefore to investigate postoperative bleeding complications prospectively in patients on chronic oral anticoagulation.
MATERIALS AND METHODS: In the period of January 2002 to December 2007, 44 patients on long-term anticoagulation with warfarin, an oral anticoagulant (OAC), underwent LC in our center. Oral anticoagulant was discontinued 5 days before the planned date of surgery, and patients were admitted to the hospital 3 days before. Upon admission, bridging anticoagulation with enoxaparin, a low molecular weight heparin (LMWH), was started. When their international normalized ratio (INR) decreased to <1.5, patients underwent LC. In the absence of postoperative bleeding complications, OAC and LMWH were resumed on the evening of the day of surgery, and LMWH was continued until each patient's target INR was reached. A comparison group was comprised by 1,421 consecutively enrolled patients with no comorbid disease who underwent LC during the same period.
RESULTS: In the comparison group, postoperative bleeding was encountered in 21 patients (1.5%). In the anticoagulation group, postoperative bleeding was encountered in 11 patients (25%) and ranged from minor oozing from a port incision in one patient to hemorrhage, sepsis, and fatality in one patient. In the anticoagulation group, no significant differences were found between patients with and without postoperative bleeding in terms of age, gender, body mass index, American Society of Anesthesiologists score, INR, or other hemostasis parameters.
CONCLUSIONS: In patients who underwent LC with bridging anticoagulation, postoperative bleeding was markedly more frequent than expected and was not predicted by the usual coagulation parameters. This suggests a need for methods that can indicate which patients on long-term anticoagulation are at risk for postoperative bleeding.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19294412     DOI: 10.1007/s00423-009-0483-y

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  18 in total

1.  The perioperative management of warfarin therapy.

Authors:  Jack E Ansell
Journal:  Arch Intern Med       Date:  2003-04-28

2.  Laparoscopic renal-adrenal surgery in patients on oral anticoagulant therapy.

Authors:  Ioannis M Varkarakis; Soroush Rais-Bahrami; Mohamad E Allaf; Guilherme C Lima; Sompol Permpongkosol; Pravin Rao; Thomas W Jarrett; Louis R Kavoussi
Journal:  J Urol       Date:  2005-09       Impact factor: 7.450

3.  The management of anticoagulation during noncardiac operations in patients with prosthetic heart valves. A prospective study.

Authors:  R E Katholi; S P Nolan; L B McGuire
Journal:  Am Heart J       Date:  1978-08       Impact factor: 4.749

4.  Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: the REGIMEN registry.

Authors:  A C Spyropoulos; A G G Turpie; A S Dunn; J Spandorfer; J Douketis; A Jacobson; F J Frost
Journal:  J Thromb Haemost       Date:  2006-06       Impact factor: 5.824

5.  Elective laparoscopic cholecystectomy for symptomatic gallstone disease in patients receiving anticoagulant therapy.

Authors:  Emmanuel Leandros; Ilias P Gomatos; Panagoula Mami; Eleftherios Kastellanos; Konstantinos Albanopoulos; Manousos M Konstadoulakis
Journal:  J Laparoendosc Adv Surg Tech A       Date:  2005-08       Impact factor: 1.878

Review 6.  Management of surgical patients receiving anticoagulation and antiplatelet agents.

Authors:  J Thachil; A Gatt; V Martlew
Journal:  Br J Surg       Date:  2008-12       Impact factor: 6.939

7.  Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin.

Authors:  M J Kovacs; C Kearon; M Rodger; D R Anderson; A G G Turpie; S M Bates; L Desjardins; J Douketis; S R Kahn; S Solymoss; P S Wells
Journal:  Circulation       Date:  2004-09-13       Impact factor: 29.690

8.  Temporary discontinuation of warfarin therapy: changes in the international normalized ratio.

Authors:  R H White; T McKittrick; R Hutchinson; J Twitchell
Journal:  Ann Intern Med       Date:  1995-01-01       Impact factor: 25.391

9.  Perioperative international normalized ratio level is a poor predictor of postoperative bleeding complications in dermatological surgery patients taking warfarin.

Authors:  C Blasdale; C M Lawrence
Journal:  Br J Dermatol       Date:  2008-01-30       Impact factor: 9.302

10.  Laparoscopic cholecystectomy in anticoagulated patients.

Authors:  S D Fitzgerald; P V Bailey; G J Liebscher; C H Andrus
Journal:  Surg Endosc       Date:  1991       Impact factor: 4.584

View more
  14 in total

1.  SAGES guidelines for the clinical application of laparoscopic biliary tract surgery.

Authors:  D Wayne Overby; Keith N Apelgren; William Richardson; Robert Fanelli
Journal:  Surg Endosc       Date:  2010-08-13       Impact factor: 4.584

2.  Bleeding and thromboembolic outcomes for patients on oral anticoagulation undergoing elective colon and rectal abdominal operations.

Authors:  Corey W Iqbal; Robert R Cima; John H Pemberton
Journal:  J Gastrointest Surg       Date:  2011-07-01       Impact factor: 3.452

3.  Results of surgery in general surgical patients receiving warfarin: retrospective analysis of 61 patients.

Authors:  Sedat Belli; Huseyin Ozgur Aytac; Hakan Yabanoglu; Erdal Karagulle; Alper Parlakgumus; Tarik Zafer Nursal; Sedat Yildirim
Journal:  Int Surg       Date:  2015-02

4.  The minimally invasive approach is associated with reduced perioperative thromboembolic and bleeding complications for patients receiving preoperative chronic oral anticoagulant therapy who undergo colorectal surgery.

Authors:  Barlas Sulu; Erman Aytac; Luca Stocchi; Jon D Vogel; Ravi P Kiran
Journal:  Surg Endosc       Date:  2012-10-24       Impact factor: 4.584

5.  Antiplatelet and Anticoagulant Medications Significantly Increase the Risk of Postoperative Hematoma: Review of over 4500 Thyroid and Parathyroid Procedures.

Authors:  Sarah C Oltmann; Amal Y Alhefdhi; Mohammad H Rajaei; David F Schneider; Rebecca S Sippel; Herbert Chen
Journal:  Ann Surg Oncol       Date:  2016-05-02       Impact factor: 5.344

6.  Laparoscopic surgery in colon cancer patients treated with chronic anti-thrombotic therapy.

Authors:  Hiroaki Nozawa; Takahide Shinagawa; Kazushige Kawai; Keisuke Hata; Toshiaki Tanaka; Takeshi Nishikawa; Kensuke Otani; Kazuhito Sasaki; Manabu Kaneko; Shigenobu Emoto; Koji Murono
Journal:  Surg Endosc       Date:  2018-01-16       Impact factor: 4.584

Review 7.  Periprocedural heparin bridging in patients receiving oral anticoagulation: a systematic review and meta-analysis.

Authors:  Jing Wen Yong; Li Xia Yang; Bright Eric Ohene; Yu Jie Zhou; Zhi Jian Wang
Journal:  BMC Cardiovasc Disord       Date:  2017-12-13       Impact factor: 2.298

8.  Impact of Comorbidity and Prescription Drugs on Haemorrhage in Cholecystectomy.

Authors:  J Strömberg; G Sandblom
Journal:  World J Surg       Date:  2017-08       Impact factor: 3.352

9.  Health and economic outcomes associated with uncontrolled surgical bleeding: a retrospective analysis of the Premier Perspectives Database.

Authors:  Mitra Corral; Nicole Ferko; Sarah Hollmann; Michael S Broder; Eunice Chang
Journal:  Clinicoecon Outcomes Res       Date:  2015-07-22

10.  Bleeding complications in cholecystectomy: a register study of over 22,000 cholecystectomies in Finland.

Authors:  S Suuronen; A Kivivuori; J Tuimala; H Paajanen
Journal:  BMC Surg       Date:  2015-08-13       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.